Plasma concentration profile of orally administered pimobendan and plasma brain natriuretic peptide level in patients with severe heart failure.
Wakaumi
Michi
M
Shiga
Tsuyoshi
T
Naganuma
Miyoko
M
Matsuda
Naoki
N
Tatami
Shinji
S
Kasanuki
Hiroshi
H
D000284:Administration, Oral; D002311:Cardiomyopathy, Dilated / Q000150:complications; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011724:Pyridazines / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
D002316:Cardiotonic Agents; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; C041648:pimobendan; C047936:UD CG 212 Cl